Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001703504 | SCV000514871 | likely benign | not provided | 2020-11-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000867355 | SCV001008568 | likely benign | Pitt-Hopkins syndrome | 2023-12-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002402129 | SCV002709312 | likely benign | Inborn genetic diseases | 2017-11-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003972581 | SCV004795704 | likely benign | TCF4-related disorder | 2023-04-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |